These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8057292)

  • 1. Mercaptoacyl amino acid inhibitors of atriopeptidase. 1. Structure-activity relationship studies of methionine and S-alkylcysteine derivatives.
    Neustadt BR; Smith EM; Nechuta TL; Bronnenkant AA; Haslanger MF; Watkins RW; Foster CJ; Sybertz EJ
    J Med Chem; 1994 Jul; 37(15):2461-76. PubMed ID: 8057292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ
    J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterocyclic lactam derivatives as dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibitors.
    Stanton JL; Sperbeck DM; Trapani AJ; Cote D; Sakane Y; Berry CJ; Ghai RD
    J Med Chem; 1993 Nov; 36(24):3829-33. PubMed ID: 8254612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-performance liquid chromatographic determination of N-[2(S)-(mercaptomethyl)-3-(2-methylphenyl)-1-oxopropyl]-L-methionine, the active plasma metabolite of a prodrug atriopeptidase inhibitor (SCH 42495), using a thiol selective (Au/Hg) amperometric detector.
    Alton KB; Hernandez A; Alvarez N; Patrick JE
    J Chromatogr; 1992 Sep; 579(2):307-17. PubMed ID: 1429978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Atriopeptidase" (EC 3.4.24.11) inhibition and protection of atrial natriuretic factor.
    Gros C; Schwartz JC; Duhamel PL; Lecomte JM; Bralet J
    Adv Nephrol Necker Hosp; 1994; 23():233-46. PubMed ID: 8154356
    [No Abstract]   [Full Text] [Related]  

  • 7. Dicarboxylic acid dipeptide neutral endopeptidase inhibitors.
    Ksander GM; Ghai RD; deJesus R; Diefenbacher CG; Yuan A; Berry C; Sakane Y; Trapani A
    J Med Chem; 1995 May; 38(10):1689-700. PubMed ID: 7752193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic factor potentiating and hemodynamic effects of SCH 42495, a new, neutral metalloendopeptidase inhibitor.
    Watkins RW; Vemulapalli S; Chiu PJ; Foster C; Smith EM; Neustadt B; Haslanger M; Sybertz EJ
    Am J Hypertens; 1993 May; 6(5 Pt 1):357-68. PubMed ID: 8512660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: rational design, bioavailability, and pharmacological responses in experimental hypertension.
    Fournié-Zaluski MC; Coric P; Turcaud S; Rousselet N; Gonzalez W; Barbe B; Pham I; Jullian N; Michel JB; Roques BP
    J Med Chem; 1994 Apr; 37(8):1070-83. PubMed ID: 8164250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutral endopeptidase-24.11 inhibitors: from analgesics to antihypertensives?
    Roques BP; Beaumont A
    Trends Pharmacol Sci; 1990 Jun; 11(6):245-9. PubMed ID: 2166369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of UK 69 578: a novel atriopeptidase inhibitor.
    Northridge DB; Jardine AG; Alabaster CT; Barclay PL; Connell JM; Dargie HJ; Dilly SG; Findlay IN; Lever AF; Samuels GM
    Lancet; 1989 Sep; 2(8663):591-3. PubMed ID: 2570286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Phosphonomethyl dipeptides and their phosphonate prodrugs, a new generation of neutral endopeptidase (NEP, EC 3.4.24.11) inhibitors.
    De Lombaert S; Erion MD; Tan J; Blanchard L; el-Chehabi L; Ghai RD; Sakane Y; Berry C; Trapani AJ
    J Med Chem; 1994 Feb; 37(4):498-511. PubMed ID: 8120868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade.
    Barclay PL; Bennett JA; Greengrass PM; Griffin A; Samuels GM; Shepperson NB
    Biochem Pharmacol; 1992 Sep; 44(6):1013-22. PubMed ID: 1417928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors.
    Robl JA; Cimarusti MP; Simpkins LM; Brown B; Ryono DE; Bird JE; Asaad MM; Schaeffer TR; Trippodo NC
    J Med Chem; 1996 Jan; 39(2):494-502. PubMed ID: 8558518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
    Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
    J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action.
    Fournie-Zaluski MC; Coric P; Thery V; Gonzalez W; Meudal H; Turcaud S; Michel JB; Roques BP
    J Med Chem; 1996 Jun; 39(13):2594-608. PubMed ID: 8691458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The atriopeptidase inhibitor UK 69,578 increases atrial natriuretic factor and causes a natriuresis in normal humans.
    Jardine AG; Connell JM; Northridge D; Dilly SG; Cussans NJ; Davidson G; Doyle J; Leckie BL; Lever AF
    Am J Hypertens; 1990 Sep; 3(9):661-7. PubMed ID: 2145871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11.
    Fink CA; Qiao Y; Berry CJ; Sakane Y; Ghai RD; Trapani AJ
    J Med Chem; 1995 Dec; 38(26):5023-30. PubMed ID: 8544178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCH 34826: an overview of its profile as a neutral endopeptidase inhibitor and ANF potentiator.
    Sybertz EJ
    Clin Nephrol; 1991 Oct; 36(4):187-91. PubMed ID: 1835684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors.
    Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H
    J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.